ID

DB10723||

名称

Fraxinus latifolia pollen

描述

Fraxinus latifolia pollen is the pollen of the Fraxinus latifolia plant. Fraxinus latifolia pollen is mainly used in allergenic testing.

cas号

唯一标识码

1FH355G8HF

状态

组

approved,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

消除途径

种类

Cell-mediated Immunity

Increased Histamine Release

Increased IgG Production

Non-Standardized Pollen Allergenic Extract

盐类

蛋白质结合

清除

同义词

language:english; code:; name;Oregon ash pollen extract

国际品牌

配送量

产品

name:Oregon Ash
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0020
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1974-04-23
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2487
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:20000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2491
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2489
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:40000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2492
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2485
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:10000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2490
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2486
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:10000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2488
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:20000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash Pollen
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-1419
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.001 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash Pollen
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-5405
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.05 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash Pollen
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-4428
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.05 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Oregon Ash Pollen
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-1420
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.1 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Washington/Oregon Coastal Tree Mixture
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0588
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-07-12
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Washington/Oregon Inland Tree Mixture
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0589
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1996-07-12
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC

混合物

name:Washington/Oregon Inland Tree Mixture
ingredients:Acer negundo pollen + Alnus rhombifolia pollen + Betula occidentalis pollen + Fraxinus latifolia pollen + Pinus contorta pollen + Pinus ponderosa pollen + Populus balsamifera subsp. trichocarpa pollen + Populus tremuloides pollen + Salix lucida ssp. lasiandra pollen
name:Washington/Oregon Coastal Tree Mixture
ingredients:Alnus rhombifolia pollen + Betula occidentalis pollen + Fraxinus latifolia pollen + Juglans nigra pollen + Juglans regia pollen + Pinus contorta pollen + Populus balsamifera subsp. trichocarpa pollen + Quercus garryana pollen + Salix lucida ssp. lasiandra pollen
name:Oregon Ash
ingredients:Fraxinus latifolia pollen
name:Oregon Ash
ingredients:Fraxinus latifolia pollen
name:Oregon Ash
ingredients:Fraxinus latifolia pollen
name:Oregon Ash
ingredients:Fraxinus latifolia pollen
name:Oregon Ash
ingredients:Fraxinus latifolia pollen
name:Oregon Ash
ingredients:Fraxinus latifolia pollen
name:Oregon Ash
ingredients:Fraxinus latifolia pollen
name:Oregon Ash
ingredients:Fraxinus latifolia pollen
name:Oregon Ash
ingredients:Fraxinus latifolia pollen
name:Oregon Ash Pollen
ingredients:Fraxinus latifolia pollen
name:Oregon Ash Pollen
ingredients:Fraxinus latifolia pollen
name:Oregon Ash Pollen
ingredients:Fraxinus latifolia pollen
name:Oregon Ash Pollen
ingredients:Fraxinus latifolia pollen

包装者

生产者

价格

受影响的生物体

剂量

form:Injection, solution
route:Intradermal; Subcutaneous
strength:0.05 g/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:0.1 g/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:10000 [PNU]/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:20000 [PNU]/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:40000 [PNU]/1mL
form:Solution
route:Intradermal; Percutaneous; Subcutaneous
strength:0.001 g/1mL
form:Solution
route:Intradermal; Percutaneous; Subcutaneous
strength:0.05 g/1mL
form:Solution
route:Intradermal; Percutaneous; Subcutaneous
strength:0.1 g/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:

atc代码

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

序列

实验性质

外部标识符

resource：PubChem Substance
identifier：347910853
resource：RxCUI
identifier：900045

外部链接

路径

目标

酶

载体

运输工具

药物反应

效应

不良反应